Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Luxdegalutamide (ARV-766) is an orally available and effective protein degrader of protein hydrolysis-targeted chimeras (PROTAC).Luxdegalutamide degrades the wild-type androgen receptor AR, as well as AR LBD mutants including those associated with the most prevalent pathogenic AR L702H, H875Y and T878A mutations.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 319.00 | |
5 mg | In stock | $ 768.00 | |
10 mg | In stock | $ 1,180.00 | |
25 mg | In stock | $ 2,160.00 | |
50 mg | In stock | $ 2,830.00 | |
100 mg | In stock | $ 3,790.00 |
Description | Luxdegalutamide (ARV-766) is an orally available and effective protein degrader of protein hydrolysis-targeted chimeras (PROTAC).Luxdegalutamide degrades the wild-type androgen receptor AR, as well as AR LBD mutants including those associated with the most prevalent pathogenic AR L702H, H875Y and T878A mutations. |
Synonyms | ARV-766 |
Molecular Weight | 807.95 |
Formula | C45H54FN7O6 |
CAS No. | 2750830-09-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Luxdegalutamide 2750830-09-0 Endocrinology/Hormones PROTAC Androgen Receptor PROTACs ARV-766 ARV 766 ARV766 inhibitor inhibit